Key stats
About KOREA INVESTMENT MANAGEMENT CO. LTD KIM ACE GLOBAL BIG PHARMA ETF
Home page
Inception date
Nov 19, 2024
Replication method
Synthetic
Dividend treatment
Distributes
Primary advisor
Korea Investment Management Co., Ltd.
ISIN
KR7497510008
KIM ACE Global Big Pharma ETF is an exchange-traded fund incorporated in South Korea. The objective of the fund is to achieve return that closely replicates the performance of Solactive Global Big Pharma Index PR
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
497510 last dividends amounted to 60.00 KRW. The quarter before, the issuer paid 112.00 KRW in dividends, which shows a 86.67% decrease.
Yes, 497510 pays dividends to its holders with the dividend yield of 0.00%. The last dividend (Aug 4, 2025) amounted to 60.00 KRW. The dividends are paid quarterly.
497510 shares are issued by Korea Investment Holdings Co., Ltd. under the brand ACE. The ETF was launched on Nov 19, 2024, and its management style is Passive.
497510 expense ratio is 0.30% meaning you'd have to pay 0.30% of your investment to help manage the fund.
497510 follows the Solactive Global Big Pharma Index - Benchmark Price Return. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.